Evidence map›Paper›PMID 42044089›Full record

ArticlePLoS computational biology2026

Refining biomarker-based clustering of cardiovascular inflammatory phenotypes in HIV using Recursive Feature Addition: A comparative evaluation approach.

Rachel Mac Cann, Dana Alalwan, Gurvin Saini, Alejandro Abner Garcia Leon, Neeltje A Kootstra, Padraig McGettrick, Aoife G Cotter, Alan Winston, Peter Reiss, Caroline Sabin and 2 more

Abstract readComparative Study
In one paragraph

Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Rachel Mac CannSchool of Medicine, University College Dublin, Belfield, Dublin, Ireland.ORCID https://orcid.org/0000-0002-5187-4002
Dana AlalwanCentre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Belfield, Dublin, Ireland.
Gurvin SainiCentre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Belfield, Dublin, Ireland.
Alejandro Abner Garcia LeonCentre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Belfield, Dublin, Ireland.
Neeltje A KootstraAmsterdam Institute for Immunology and Infectious Diseases, Amsterdam, The Netherlands.
Padraig McGettrickSchool of Medicine, University College Dublin, Belfield, Dublin, Ireland.
Aoife G CotterSchool of Medicine, University College Dublin, Belfield, Dublin, Ireland.
Alan WinstonDepartment of Infectious Disease, Imperial College London, London, United Kingdom.ORCID https://orcid.org/0000-0002-5847-8416
Peter ReissAmsterdam Institute for Immunology and Infectious Diseases, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0001-7896-6428
Caroline SabinInstitute for Global Health, University College London, London, United Kingdom.ORCID https://orcid.org/0000-0001-5173-2760
Patrick W MallonSchool of Medicine, University College Dublin, Belfield, Dublin, Ireland.
UPBEAT-CAD, AIID and COBRA cohorts

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPeople living with HIV remain at elevated risk for a number of non-communicable diseases, including cardiovascular disease (CVD), driven in part by chronic inflammation. While prior studies have identified inflammatory biomarker patterns linked to CVD in people with HIV, it remains unclear which combinations of biomarkers most effectively predict clinical outcomes. We aimed to develop and evaluate a framework for refining biomarker-based clustering approaches to better capture inflammatory patterns associated with a cardiovascular phenotype (CVP) in people with HIV.

methodsWe developed and evaluated three recursive feature addition (RFA) models to enhance biomarker-driven clustering of people with and without HIV. Using a 24-marker initial panel of biomarkers chosen for their links to clinical CVP in people with HIV, we compared three models for selective inclusion of 31 additional, exploratory biomarkers: (1) a stepwise additive model evaluating biomarkers cumulatively based on biological relevance; (2) a stepwise additive model evaluating biomarkers individually; and (3) a greedy forward-backward selection model. Each model was assessed using principal component analysis (PCA), cluster stability, biological coherence and association with a CVP and 10-year Atherosclerotic Cardiovascular Disease (ASCVD) risk.

resultsAll three RFA models generated three, biomarker-derived clusters. Post RFA cluster biomarker composition, model stability and clinical associations of these clusters differed across models. The individual additive model (Model 2) produced the most distinct separation of inflammatory profiles, incorporating 11 additional biomarkers, including, GDF-15, IFN-λ2 and Thrombopoietin). In this model, Cluster 3 was characterised by heightened innate and adaptive immune activation, the highest CVP prevalence (11%) and the strongest association with CVP (adjusted odds ratio (aOR) 2.3, 95% CI 1.04-5.09).

conclusionWe demonstrate that an RFA framework using a stepwise, additive model evaluating biomarkers individually to enhance clustering profiles provides optimal unsupervised clustering of exploratory biomarkers to reveal additional associations between inflammatory patterns and CVP in people with and without HIV.

Indexed as

BiomarkersCardiovascular DiseasesHIV InfectionsInflammationCluster AnalysisClustering AlgorithmsComputational BiologyFemaleHumansMalePhenotypePrincipal Component AnalysisBiomarkers

Identifiers

PMID42044089
PMCPMC13119895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.